Loading...
XNAS
NNOX
Market cap328mUSD
May 28, Last price  
5.15USD
1D
-0.58%
1Q
-14.59%
IPO
-80.71%
Name

Nano-X Imaging Ltd

Chart & Performance

D1W1MN
XNAS:NNOX chart
No data to show
P/E
P/S
33.15
EPS
Div Yield, %
Shrs. gr., 5y
10.53%
Rev. gr., 5y
%
Revenues
10m
+15.47%
0001,304,0008,578,0009,905,000
Net income
-61m
L-42.25%
-1,909,000-22,555,000-43,499,000-61,798,000-105,243,000-60,776,000
CFO
-45m
L+3.21%
-3,671,000-5,524,000-21,487,000-38,071,000-43,385,000-44,777,000
Earnings
Aug 18, 2025

Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
IPO date
Aug 21, 2020
Employees
180
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
9,905
15.47%
8,578
557.82%
Cost of revenue
70,940
87,595
Unusual Expense (Income)
NOPBT
(61,035)
(79,017)
NOPBT Margin
Operating Taxes
(339)
(3,678)
Tax Rate
NOPAT
(60,696)
(75,339)
Net income
(60,776)
-42.25%
(105,243)
70.30%
Dividends
Dividend yield
Proceeds from repurchase of equity
27,139
949
BB yield
-7.56%
-0.25%
Debt
Debt current
4,351
740
Long-term debt
8,951
5,017
Deferred revenue
398
Other long-term liabilities
612
4,572
Net debt
(69,408)
(97,065)
Cash flow
Cash from operating activities
(44,777)
(43,385)
CAPEX
(3,303)
(7,171)
Cash from investing activities
35,433
14,606
Cash from financing activities
27,252
804
FCF
(62,910)
(80,881)
Balance
Cash
82,383
77,624
Long term investments
327
25,198
Excess cash
82,215
102,393
Stockholders' equity
(320,373)
(253,273)
Invested Capital
524,895
487,542
ROIC
ROCE
EV
Common stock shares outstanding
56,368
52,235
Price
6.37
-13.69%
7.38
-49.24%
Market cap
359,064
-6.86%
385,494
-45.01%
EV
289,656
288,429
EBITDA
(49,225)
(67,505)
EV/EBITDA
Interest
60,215
Interest/NOPBT